A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies Journal Article


Authors: Liu, X.; Devadiga, S. A.; Stanley, R. F.; Morrow, R. M.; Janssen, K. A.; Quesnel-Vallières, M.; Pomp, O.; Moverley, A. A.; Li, C.; Skuli, N.; Carroll, M.; Huang, J.; Wallace, D. C.; Lynch, K. W.; Abdel-Wahab, O.; Klein, P. S.
Article Title: A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies
Abstract: Splicing factor mutations are common in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), but how they alter cellular functions is unclear. We show that the pathogenic SRSF2P95H/+ mutation disrupts the splicing of mitochondrial mRNAs, impairs mitochondrial complex I function, and robustly increases mitophagy. We also identified a mitochondrial surveillance mechanism by which mitochondrial dysfunction modifies splicing of the mitophagy activator PINK1 to remove a poison intron, increasing the stability and abundance of PINK1 mRNA and protein. SRSF2P95H-induced mitochondrial dysfunction increased PINK1 expression through this mechanism, which is essential for survival of SRSF2P95H/+ cells. Inhibition of splicing with a glycogen synthase kinase 3 inhibitor promoted retention of the poison intron, impairing mitophagy and activating apoptosis in SRSF2P95H/+ cells. These data reveal a homeostatic mechanism for sensing mitochondrial stress through PINK1 splicing and identify increased mitophagy as a disease marker and a therapeutic vulnerability in SRSF2P95H mutant MDS and AML. Copyright: © 2024, Liu et al.
Journal Title: Journal of Clinical Investigation
Volume: 134
Issue: 12
ISSN: 0021-9738
Publisher: American Society for Clinical Investigation  
Date Published: 2024-06-17
Start Page: e175619
Language: English
DOI: 10.1172/jci175619
PUBMED: 38713535
PROVIDER: scopus
PMCID: PMC11178535
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Stanley
    12 Stanley